Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Salivary gland neoplasm
ADR ID BADD_A10878
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.14      Salivary gland neoplasms unspecified malignancy
16.13.14.001      Salivary gland neoplasm
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.08      Oral cavity neoplasms NEC
07.21.08.004      Salivary gland neoplasm
Description Tumors or cancer of the SALIVARY GLANDS. [MeSH]
MedDRA Code 10061497
MeSH ID D012468
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Neoplasm of uncertain behavior of major salivary glands | Neoplasm of uncertain behaviour of major salivary glands | Salivary gland neoplasm NOS | Parotid tumour | Parotid tumor | Salivary gland neoplasm | Salivary Gland Neoplasms | Gland Neoplasm, Salivary | Gland Neoplasms, Salivary | Neoplasm, Salivary Gland | Salivary Gland Neoplasm | Neoplasms, Salivary Gland | Cancer of Salivary Gland | Salivary Gland Cancers | Cancer of the Salivary Gland | Salivary Gland Cancer | Cancer, Salivary Gland | Cancers, Salivary Gland
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01392Mercaptopurine--
BADD_D02236Tofacitinib0.000241%
The 1th Page    1    Total 1 Pages